TRUHEPLI
"TRUHEPLI" is a word mark owned by Mirum Pharmaceuticals, Inc., filed at the USPTO on October 9, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since October 9, 2026
- Filed
- October 9, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50153651
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns TRUHEPLI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Mirum Pharmaceuticals, Inc.
MIRM · Foster City, United States
Representative
Karl M. Zielaznicki
Troutman Pepper Locke LLP
What the mark covers
The products and services TRUHEPLI is filed for, grouped by Nice class.
Pharmaceutical preparations for use in the treatment and prevention of hepatitis D infections, hepatitis B infections, fulminant hepatitis, liver cirrhosis, hepatocellular carcinoma, and liver failure.
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About TRUHEPLI
Who owns the trademark "TRUHEPLI"?
The USPTO trademark "TRUHEPLI" (application 50153651) is owned by Mirum Pharmaceuticals, Inc.
What is the status of "TRUHEPLI"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull TRUHEPLI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a12881-ec9b-76c1-8162-d23eb1767b13
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a12881-ec9b-76c1-8162-d23eb1767b13",
"object": "trademark",
"mark_text": "TRUHEPLI",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50153651",
"filing_date": "2026-10-09",
"nice_classes": [
5
],
"owners": [
{
"name": "Mirum Pharmaceuticals, Inc.",
"entity_id": "ent_019f2861-40f4-72e7-883c-383400c498c0"
}
]
}